Cleared Traditional

K900723 - ITC BUNJI COIL

K900723 is an FDA 510(k) clearance for ITC BUNJI COIL, manufactured by Interventional Therapeutics Corp.. The device is a Class 2 Neurology device with product code HCG cleared through the Traditional 510(k) pathway after a 369-day FDA review.

K900723 · Interventional Therapeutics Corp. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1991
Decision
369d
Days
Class 2
Risk

K900723 is an FDA 510(k) clearance for the ITC BUNJI COIL. Classified as Device, Neurovascular Embolization (product code HCG), Class II - Special Controls.

Submitted by Interventional Therapeutics Corp. (South San Francisco, US). The FDA issued a Cleared decision on February 19, 1991 after a review of 369 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5950 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Interventional Therapeutics Corp. devices

FDA 510(k) Submission Details - K900723

510(k) Number K900723 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 1990
Decision Date February 19, 1991
Days to Decision 369 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
221d slower than avg
Panel avg: 148d · This submission: 369d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCG Device Classification - Class 2, Special Controls

Product Code HCG Device, Neurovascular Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5950
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCG Device, Neurovascular Embolization

All 157
Devices cleared under the same product code (HCG) and FDA review panel - the closest regulatory comparables to K900723.
ITC BUNJI COIL (MODIFICATION)
K920324 · Interventional Therapeutics Corp. · Jul 1992
HELIX SHAPED COILS WITH DACRON FIBERS, MODIFIED
K911779 · Target Therapeutics · Nov 1991
HELIX SHAPED COILS WITH DACRON FIBERS, MODIFIED
K913312 · Target Therapeutics · Nov 1991
HILAL EMBOLIZATION MICROCOIL(TM)
K901337 · Cook, Inc. · Nov 1990
MODIFIED TARGET THERAPEUTICS COILS
K901721 · Target Therapeutics · Jul 1990
COIL AND COIL DELIVERY SYSTEM
K891688 · Target Therapeutics · Sep 1989